These PTMs of HIF1α-interacting TFs drive their stability and activity, degradation and turnover, and bidirectional translocation between the cytoplasm or plasma membrane and nucleus of BC cells, as well as transcription/activation of proteins encoded by oncogenes or inactivation of tumor suppressor target genes. This evidence concerns the gene HIF1A and breast cancer.